Forty Five Thousand Crore Market Cap Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 13, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Ipca Labs Rs 1,900. Mphasis Rs 2,410. Navin Fluorine Rs 9,969. PB Fintech Rs 1,050. Sundaram Finance Rs 4,420. NSE closing prices, 12 Nov 2026.
Quick Answer
Five forty five thousand crore market cap stocks to buy on the November 2026 watchlist are Ipca Laboratories, Mphasis, Navin Fluorine International, PB Fintech and Sundaram Finance. All five grew revenue in their latest full year, and all five also grew net profit. Sundaram Finance has the lowest P/E at 19.62, while Mphasis leads on return on equity at 17.34%. Check each valuation against your own risk appetite before acting.
The forty five thousand crore market cap stocks to buy in November 2026 start with five listed names: Ipca Laboratories, Mphasis, Navin Fluorine International, PB Fintech and Sundaram Finance. These five companies are each valued between about Rs 43,500 crore and Rs 48,900 crore, a size that sits in the upper mid cap range. Mphasis is part of the Nifty IT index.
This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these forty five thousand crore market cap stocks to buy to a portfolio. All prices are NSE closing prices of 12 November 2026, and financials come from company filings.
Click Here – Get Free Investment Predictions
Which Are the Best Forty Five Thousand Crore Market Cap Stocks to Buy in November 2026?
The best forty five thousand crore market cap stocks to buy in November 2026 for a watchlist are Ipca Laboratories, Mphasis, Navin Fluorine International, PB Fintech and Sundaram Finance. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.
| Company | CMP (Rs) | Market Cap | P/E | ROE | Dividend Yield |
|---|---|---|---|---|---|
| Ipca Laboratories | 1,900 | Rs 48,860 crore | 35.53 | 14.15% | 0.31% |
| Mphasis | 2,410 | Rs 48,565 crore | 25.42 | 17.34% | 2.44% |
| Navin Fluorine International | 9,969 | Rs 43,617 crore | 55.23 | 16.69% | 0.10% |
| PB Fintech | 1,050 | Rs 47,104 crore | 62.95 | 9.16% | 0.00% |
| Sundaram Finance | 4,420 | Rs 43,563 crore | 19.62 | 13.82% | 1.02% |
On valuation, PB Fintech trades below the industry P/E; Ipca Laboratories sits close to it; Mphasis, Navin Fluorine International and Sundaram Finance carry a premium. Valuation is the first filter for any forty five thousand crore market cap stocks to buy list, and it is covered again in the risk section.
Why These Forty Five Thousand Crore Market Cap Stocks to Buy Are in Focus
In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the latest reported quarter was higher than a year earlier for all five. The list covers a pharma company, an IT services company, a specialty fluorine chemicals company, the operator of Policybazaar and a vehicle finance company. Investors comparing the best forty five thousand crore market cap stocks in India usually check earnings growth, dividends and how the shares are valued.
Ipca Laboratories: The Formulations and API Name Among Forty Five Thousand Crore Market Cap Stocks to Buy
Ipca Laboratories is a pharma company making formulations and active ingredients, known for anti-malarial and pain-management products. Its market capitalisation is Rs 48,860 crore, the share price is Rs 1,900 and the P/E of 35.53 compares with an industry P/E of 37.65.
Over FY26, net profit rose 51.3% to Rs 1,191 crore on revenue of Rs 9,821 crore, which was up 8.7%. The latest quarter, the June 2026 quarter, brought revenue of Rs 2,813 crore, up 20.2% year on year, and net profit of Rs 423 crore, up 80.4%.
Return on equity is 14.15%, debt-to-equity is 0.10, and the dividend yield is 0.31%. Promoters hold 44.72%, foreign institutions 11.53% and domestic institutions 36.59% as of September 2026. Foreign institutional holding has risen from 10.43% to 11.53% over the last year.
Mphasis: The BFSI-Focused Services Name Among Forty Five Thousand Crore Market Cap Stocks to Buy
Mphasis is an IT services company focused on banking, financial services and technology clients. The stock trades at Rs 2,410 with a market capitalisation of Rs 48,565 crore and a P/E of 25.42, against an industry P/E of 18.92.
FY26 revenue rose 11.9% to Rs 16,206 crore and net profit rose 9.4% to Rs 1,863 crore. In the June 2026 quarter, revenue grew 17.1% year on year to Rs 4,467 crore, while net profit grew 10.8% to Rs 490 crore.
Return on equity is 17.34%, debt-to-equity is 0.24, and the dividend yield is 2.44%. Promoters hold 30.53%, foreign institutions 19.39% and domestic institutions 45.85% as of September 2026. Domestic institutional holding has risen from 37.07% to 45.85% over the last year.
Check Forty Five Thousand Crore Market Cap Stocks Live on the Univest Screener
Navin Fluorine International: The Fluorine Specialist Among Forty Five Thousand Crore Market Cap Stocks to Buy
Navin Fluorine International is a fluorine speciality chemicals, refrigerant gas and contract research and manufacturing company. At Rs 9,969, the stock has a market capitalisation of Rs 43,617 crore and trades at 55.23 times earnings, while the industry P/E is 33.45.
Reported numbers show FY26 revenue of Rs 3,379 crore, up 41.2% year on year, with net profit at Rs 664 crore, up 129.9%. The June 2026 quarter added revenue of Rs 1,080 crore (up 46.1%) and net profit of Rs 243 crore (up 107.7%).
Return on equity is 16.69%, debt-to-equity is 0.32, and the dividend yield is 0.10%. Promoters hold 27.08%, foreign institutions 23.38% and domestic institutions 28.70% as of September 2026. Foreign institutional holding has risen from 22.15% to 23.38% over the last year.
PB Fintech: The Online Insurance Marketplace Among Forty Five Thousand Crore Market Cap Stocks to Buy
PB Fintech is the owner of the Policybazaar and Paisabazaar online marketplaces for insurance and loans. Its market capitalisation is Rs 47,104 crore, the share price is Rs 1,050 and the P/E of 62.95 compares with an industry P/E of 116.33.
Over FY26, net profit rose 89.8% to Rs 670 crore on revenue of Rs 7,166 crore, which was up 33.1%. The latest quarter, the June 2026 quarter, brought revenue of Rs 1,981 crore, up 36.9% year on year, and net profit of Rs 163 crore, up 92.4%.
Return on equity is 9.16%, and the dividend yield is negligible. The company has no identified promoter, with foreign institutions holding 27.12% and domestic institutions 39.97% as of September 2026. Domestic institutional holding has risen from 26.62% to 39.97% over the last year. A point to keep in view: at a P/E of 62.95, expectations are already high.
Sundaram Finance: The Vehicle Finance Veteran Among Forty Five Thousand Crore Market Cap Stocks to Buy
Sundaram Finance is a long-established vehicle finance company in the TVS group. The stock trades at Rs 4,420 with a market capitalisation of Rs 43,563 crore and a P/E of 19.62, against an industry P/E of 16.13.
FY26 revenue rose 15.3% to Rs 9,873 crore and net profit rose 10.6% to Rs 2,005 crore. In the June 2026 quarter, revenue grew 12.8% year on year to Rs 2,653 crore, while net profit grew 38.1% to Rs 569 crore.
Return on equity is 13.82%, and the dividend yield is 1.02%. Promoters hold 37.19%, foreign institutions 17.99% and domestic institutions 8.88% as of September 2026. Domestic institutional holding has risen from 6.84% to 8.88% over the last year.
Download the Univest iOS App or Univest Android App to track these forty five thousand crore market cap stocks live and get daily stock recommendations.
Growth Snapshot: Latest Full Year and Latest Quarter
The table compares year-on-year growth in revenue and net profit for all five forty five thousand crore market cap stocks, using filed results.
| Company | Full-Year Revenue Growth | Full-Year Profit Growth | Latest Quarter | Quarter Revenue Growth | Quarter Profit Growth |
|---|---|---|---|---|---|
| Ipca Laboratories | 8.7% | 51.3% | Jun 2026 | 20.2% | 80.4% |
| Mphasis | 11.9% | 9.4% | Jun 2026 | 17.1% | 10.8% |
| Navin Fluorine International | 41.2% | 129.9% | Jun 2026 | 46.1% | 107.7% |
| PB Fintech | 33.1% | 89.8% | Jun 2026 | 36.9% | 92.4% |
| Sundaram Finance | 15.3% | 10.6% | Jun 2026 | 12.8% | 38.1% |
Factors That Move Forty Five Thousand Crore Market Cap Stocks to Buy
Four factors tend to drive forty five thousand crore market cap stocks, and each one is worth checking before a purchase.
- Company size: Each is valued above Rs 43,000 crore.
- Dividends: Mphasis yields about 2.4%.
- Return on equity: Mphasis leads at about 17%.
- Valuation: P/E runs from about 20 to 63.
Risks to Keep in Mind Before Buying Forty Five Thousand Crore Market Cap Stocks
The first risk is that PB Fintech trades at a P/E near 63 and Navin Fluorine International near 55, while Sundaram Finance trades near 20, so expectations differ widely. The second is that Sundaram Finance carries the highest borrowings of the five as a lender. Check results every quarter.
On the numbers, PB Fintech trades at the highest P/E on this list at 62.95, so its earnings need to keep growing to support the price. Forty Five Thousand Crore Market Cap stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.
How to Choose Forty Five Thousand Crore Market Cap Stocks to Buy
- Compare growth: Navin Fluorine International grew FY26 profit most, by about 130%.
- Check P/E: Sundaram Finance trades lowest.
- Read the yield: Mphasis pays the most.
- Spread sectors: Mix pharma, IT, chemicals, insurance marketplace and vehicle finance.
How to Invest in Forty Five Thousand Crore Market Cap Stocks
- Shortlist two or three companies from this list that match your risk appetite.
- Open the Univest Screener and compare P/E, ROE and debt for each stock.
- Check the latest quarterly results and shareholding pattern on NSE or BSE.
- Decide an amount you can hold for three to five years and split it into two or three purchases.
- Review the holding after every quarterly result instead of reacting to daily price moves.
Conclusion
Sundaram Finance offers the lowest P/E on this list at 19.62, Mphasis has the highest return on equity at 17.34%, and Navin Fluorine International posted the fastest net profit growth in its latest full year at 129.9%. Among the best forty five thousand crore market cap stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these forty five thousand crore market cap stocks to buy.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Forty Five Thousand Crore Market Cap Stocks to Buy
Which are the best forty five thousand crore market cap stocks to buy in November 2026?
Ans. The five forty five thousand crore market cap stocks on the November 2026 watchlist are Ipca Laboratories, Mphasis, Navin Fluorine International, PB Fintech and Sundaram Finance. Sundaram Finance has the lowest P/E at 19.62, Mphasis has the highest ROE at 17.34%, and Navin Fluorine International grew net profit 129.9% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.
Is Ipca Laboratories a good stock to buy from this Forty Five Thousand Crore Market Cap list?
Ans. Ipca Laboratories is the largest company on this list with a market capitalisation of Rs 48,860 crore and a P/E of 35.53 against an industry P/E of 37.65. Its FY26 revenue rose 8.7% and net profit rose 51.3%, with return on equity at 14.15%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.
Are these forty five thousand crore market cap stocks expensive right now?
Ans. Valuations vary across the group. Ipca Laboratories trades at a P/E of 35.53, Mphasis trades at a P/E of 25.42, Navin Fluorine International trades at a P/E of 55.23, PB Fintech trades at a P/E of 62.95, Sundaram Finance trades at a P/E of 19.62, against industry multiples ranging from 16.13 to 116.33. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.
Which of these forty five thousand crore market cap stocks pay a dividend?
Ans. Dividend yields on this list are Ipca Laboratories 0.31%, Mphasis 2.44%, Navin Fluorine International 0.10%, Sundaram Finance 1.02%. Yields differ widely across the group, so check payout history and earnings cover before relying on any of them for income, since payouts can change with company profits.
Which stock on this list has the highest return on equity?
Ans. Mphasis has the highest ROE on this list at 17.34%, followed by Navin Fluorine International at 16.69% and Ipca Laboratories at 14.15%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.
What are the risks of investing in forty five thousand crore market cap stocks?
Ans. The main risks are high valuations at two names, borrowings at the vehicle lender and a wide spread in sectors. On this list, PB Fintech trades at the highest P/E of 62.95, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.
How can I invest in forty five thousand crore market cap stocks in India?
Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.
